Investors Sell UnitedHealth Group (UNH) on Strength (UNH)
Traders sold shares of UnitedHealth Group Inc (NYSE:UNH) on strength during trading on Tuesday. $342.45 million flowed into the stock on the tick-up and $419.71 million flowed out of the stock on the tick-down, for a money net flow of $77.26 million out of the stock. Of all companies tracked, UnitedHealth Group had the 11th highest net out-flow for the day. UnitedHealth Group traded up $4.26 for the day and closed at $232.90
Several equities research analysts recently commented on the company. Cantor Fitzgerald reiterated a “buy” rating and set a $235.00 target price on shares of UnitedHealth Group in a report on Tuesday. Wells Fargo & Co reiterated an “outperform” rating and set a $245.00 target price (up from $230.00) on shares of UnitedHealth Group in a report on Wednesday, November 29th. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Friday, December 1st. Evercore ISI reiterated an “outperform” rating and set a $255.00 target price (up from $235.00) on shares of UnitedHealth Group in a report on Friday. Finally, Citigroup raised their target price on UnitedHealth Group from $213.00 to $235.00 and gave the company a “buy” rating in a report on Wednesday, October 18th. Three equities research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $229.54.
The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. The firm has a market cap of $225,180.00, a price-to-earnings ratio of 26.47, a PEG ratio of 1.54 and a beta of 0.66.
In other news, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the sale, the director now directly owns 61,137 shares in the company, valued at approximately $13,652,503.47. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $221.75, for a total value of $5,011,106.50. Following the completion of the sale, the chief executive officer now owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders sold a total of 34,630 shares of company stock valued at $7,669,416 over the last quarter. Company insiders own 0.89% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the company. Blue Chip Partners Inc. bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at approximately $110,000. Bruderman Asset Management LLC acquired a new position in UnitedHealth Group during the 2nd quarter valued at approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its position in UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the period. BDO Wealth Advisors LLC acquired a new position in UnitedHealth Group during the 2nd quarter valued at approximately $121,000. Finally, Acrospire Investment Management LLC boosted its position in UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 400 shares during the period. Institutional investors and hedge funds own 86.09% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.